NIH wants to end bad data

Share this article:

The NIH is cracking down on bad data. The US agency announced in Nature that the research field is plagued by data that cannot be replicated, and points the finger not at fraud, but at poor training and the wrong publishing incentives, among other factors.

To correct this problem, the NIH said it is developing training modules that should increase “reproducibility and transparency of research findings.” The NIH also wants to put pressure on academic institutions to demand more of research, and says the current focus on big-name journals and budgetary pressures “encourages rapid submission of research findings to the detriment of careful replication” and says it may rework its NIH grant applications to better define the role each applicant played in the study, among other changes.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.